Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 575

1.

The long-term outcomes of Gleason grade groups 2 and 3 prostate cancer managed by active surveillance: Results from a large population-based cohort.

Richard PO, Timilshina N, Komisarenko M, Martin L, Ahmad A, Alibhai SMH, Hamilton RJ, Kulkarni G, Finelli A.

Can Urol Assoc J. 2020 Jan 20. doi: 10.5489/cuaj.6328. [Epub ahead of print]

PMID:
31977306
2.

Modifiable Lifestyle Behaviours Impact the Health-Related Quality of Life of Bladder Cancer Survivors.

Chung J, Maganti M, Kulkarni GS, Morash R, Matthew A, Papadakos J, Breau RH, Guttman D, Bender J, Jones JM.

BJU Int. 2020 Jan 24. doi: 10.1111/bju.15007. [Epub ahead of print]

PMID:
31977152
3.

Role of MRI in Staging of Penile Cancer.

Krishna S, Shanbhogue K, Schieda N, Morbeck F, Hadas B, Kulkarni G, McInnes MD, Baroni RH.

J Magn Reson Imaging. 2020 Jan 24. doi: 10.1002/jmri.27060. [Epub ahead of print]

PMID:
31976600
4.

Simple synthesis of nanosheets of rGO and nitrogenated rGO.

Chithaiah P, Raju MM, Kulkarni GU, Rao CNR.

Beilstein J Nanotechnol. 2020 Jan 7;11:68-75. doi: 10.3762/bjnano.11.7. eCollection 2020.

5.

Rapid and sensitive detection of drugs of abuse in sweat by multiplexed capillary based immuno-biosensors.

Xue W, Tan X, Khaing Oo MK, Kulkarni G, Ilgen MA, Fan X.

Analyst. 2020 Jan 22. doi: 10.1039/c9an02498k. [Epub ahead of print]

PMID:
31967116
6.

Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model.

Kasendra M, Luc R, Yin J, Manatakis DV, Kulkarni G, Lucchesi C, Sliz J, Apostolou A, Sunuwar L, Obrigewitch J, Jang KJ, Hamilton GA, Donowitz M, Karalis K.

Elife. 2020 Jan 14;9. pii: e50135. doi: 10.7554/eLife.50135.

7.

Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials.

Magee DE, Hird AE, Klaassen Z, Sridhar SS, Nam RK, Wallis CJD, Kulkarni GS.

Ann Oncol. 2020 Jan;31(1):50-60. doi: 10.1016/j.annonc.2019.10.008. Review.

PMID:
31912796
8.

Complications after surgery for benign prostatic enlargement: a population-based cohort study in Ontario, Canada.

Matta R, Dvorani E, Wallis C, Hird A, LaBossiere J, Kulkarni G, Kodama R, Carr L, Radomski SB, Saskin R, Herschorn S, Nam RK.

BMJ Open. 2019 Dec 30;9(12):e032170. doi: 10.1136/bmjopen-2019-032170.

9.

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis.

Ahmad AE, Mohammed A, Bhindi B, Richard PO, Fadaak K, Leão R, Finelli A, Fleshner NE, Kulkarni GS.

Cancer Manag Res. 2019 Nov 29;11:10043-10050. doi: 10.2147/CMAR.S226174. eCollection 2019.

10.

Letter to Editor to the Article "Pretreatment Blood Pressure is a Simple Predictor of Hemorrhagic Infarction after Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) Therapy".

Kamath SD, Taallapalli AVR, Kulkarni GB.

J Stroke Cerebrovasc Dis. 2019 Dec 4:104535. doi: 10.1016/j.jstrokecerebrovasdis.2019.104535. [Epub ahead of print] No abstract available.

PMID:
31812454
11.

Narrowing Desiccating Crack Patterns by an Azeotropic Solvent for the Fabrication of Nanomesh Electrodes.

Pujar R, Kumar A, Rao KDM, Sadhukhan S, Dutta T, Tarafdar S, Kulkarni GU.

Langmuir. 2019 Dec 10;35(49):16130-16135. doi: 10.1021/acs.langmuir.9b02442. Epub 2019 Nov 21.

PMID:
31710498
12.

Reproducing human and cross-species drug toxicities using a Liver-Chip.

Jang KJ, Otieno MA, Ronxhi J, Lim HK, Ewart L, Kodella KR, Petropolis DB, Kulkarni G, Rubins JE, Conegliano D, Nawroth J, Simic D, Lam W, Singer M, Barale E, Singh B, Sonee M, Streeter AJ, Manthey C, Jones B, Srivastava A, Andersson LC, Williams D, Park H, Barrile R, Sliz J, Herland A, Haney S, Karalis K, Ingber DE, Hamilton GA.

Sci Transl Med. 2019 Nov 6;11(517). pii: eaax5516. doi: 10.1126/scitranslmed.aax5516.

PMID:
31694927
13.

Conservative Management of Fused and Geminated Permanent Anterior Teeth.

Kim EC, Symington O, Kulkarni G.

J Dent Child (Chic). 2019 Sep 15;86(3):164-168.

PMID:
31645259
14.

Nanoantibiotic Formulations to Combat Antibiotic Resistance - Old Wine in a New Bottle.

Rana R, Awasthi R, Sharma B, Kulkarni GT.

Recent Pat Drug Deliv Formul. 2019;13(3):174-183. doi: 10.2174/1872211313666190911124626.

PMID:
31544718
15.

Formation of Two-Dimensional Network of Organic Charge-Transfer Complexes at the Air-Water Interface.

Bhattacharyya A, Sanyal MK, Mogera U, George SJ, Dhiman S, Kulkarni GU, Fontaine P.

Langmuir. 2019 Oct 1;35(39):12630-12635. doi: 10.1021/acs.langmuir.9b01635. Epub 2019 Sep 18.

PMID:
31532685
16.

A novel predictor of clinical progression in patients on active surveillance for prostate cancer.

Tan GH, Finelli A, Ahmad A, Wettstein MS, Chandrasekar T, Zlotta AR, Fleshner NE, Hamilton RJ, Kulkarni GS, Ajib K, Nason G, Perlis N.

Can Urol Assoc J. 2019 Aug;13(8):250-255. doi: 10.5489/cuaj.6122. Epub 2019 Aug 31.

17.

Age Differences in Patient-reported Psychological and Physical Distress Symptoms in Bladder Cancer Patients - A Cross Sectional Study.

Ajaj R, Berlin A, Klaassen Z, Chandrasekar T, Wallis CJD, Ahmad AE, Herrera Cáceres JO, Leao R, Petrella AR, Fleshner N, Matthew A, Kulkarni GS, Goldberg H.

Urology. 2019 Dec;134:154-162. doi: 10.1016/j.urology.2019.08.032. Epub 2019 Sep 2.

PMID:
31487512
18.

Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.

Singh AK, Mishra G, Maurya A, Awasthi R, Kumari K, Thakur A, Rai A, Rai GK, Sharma B, Kulkarni GT, Singh SK.

Curr Alzheimer Res. 2019;16(13):1216-1229. doi: 10.2174/1567205016666190903102822.

PMID:
31481003
19.

Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada.

Wettstein MS, Palmer KS, Kulkarni GS, Paterson JM, Ling V, Lapointe-Shaw L, Li AH, Brown A, Taljaard M, Ivers N.

JAMA Netw Open. 2019 Aug 2;2(8):e1910505. doi: 10.1001/jamanetworkopen.2019.10505.

20.

Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.

Singh AK, Singh SK, Nandi MK, Mishra G, Maurya A, Rai A, Rai GK, Awasthi R, Sharma B, Kulkarni GT.

Cent Nerv Syst Agents Med Chem. 2019;19(3):154-170. doi: 10.2174/1871524919666190820160053.

PMID:
31429696
21.

Ice nucleation ability of loess from the northwestern United States.

Kulkarni G.

PLoS One. 2019 Aug 9;14(8):e0220991. doi: 10.1371/journal.pone.0220991. eCollection 2019.

22.

Potential of isoquercitrin as antisickling agent: a multi-spectroscopic, thermophoresis and molecular modeling approach.

Syed MM, Doshi PJ, Dhavale DD, Doshi JB, Kate SL, Kulkarni G, Sharma N, Uppuladinne M, Sonavane U, Joshi R, Kulkarni MV.

J Biomol Struct Dyn. 2019 Aug 1:1-20. doi: 10.1080/07391102.2019.1645735. [Epub ahead of print]

PMID:
31315526
23.

Reply to Comment on: "The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies''.

Klaassen Z, Wallis CJD, Kurdyak P, Kulkarni GS.

Br J Cancer. 2019 Jul;121(2):195-196. doi: 10.1038/s41416-019-0494-6. Epub 2019 Jun 10. No abstract available.

PMID:
31178590
24.

MOG antibody seropositive aseptic meningitis: A new clinical phenotype.

Nagabushana D, Shah R, Pendharkar H, Agrawal A, Kulkarni GB, Rajendran S, Alladi S, Mahadevan A.

J Neuroimmunol. 2019 Aug 15;333:476960. doi: 10.1016/j.jneuroim.2019.05.001. Epub 2019 May 2.

PMID:
31108402
25.

Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy.

McAlpine K, Lavallée LT, Stacey D, Moodley P, Cagiannos I, Morash C, Black PC, Kulkarni GS, Shayegan B, Kassouf W, Siemens R, So A, Leveridge MJ, Boorjian SA, Daneshmand S, Smith AB, Power N, Izawa J, Drachenberg DE, Fairey A, Rendon RA, Breau RH.

J Urol. 2019 Nov;202(5):1001-1007. doi: 10.1097/JU.0000000000000341. Epub 2019 Oct 9.

PMID:
31099720
26.

Photoselective vaporization of the prostate: study outcomes as a function of risk of bias, conflicts of interest, and industrial sponsorship.

Wettstein MS, Pazhepurackel C, Neumann AS, Woon DTS, Herrera-Caceres JO, Kozomara M, Poyet C, Sulser T, Kulkarni GS, Hermanns T.

World J Urol. 2019 May 13. doi: 10.1007/s00345-019-02799-3. [Epub ahead of print]

PMID:
31087122
27.

Reply by Authors.

Richard PO, Bashir S, Riverin BD, Alibhai SMH, Kim SJ, Ahmad A, Fleshner NE, Gupta A, Mohammed A, Zlotta AR, Kulkarni GS.

J Urol. 2019 Aug;202(2):325. doi: 10.1097/01.JU.0000558494.56102.db. Epub 2019 Jul 8. No abstract available.

PMID:
31042130
28.

Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?

Wettstein MS, Rooprai JK, Pazhepurackel C, Wallis CJD, Klaassen Z, Uleryk EM, Hermanns T, Fleshner NE, Zlotta AR, Kulkarni GS.

PLoS One. 2019 Apr 29;14(4):e0216255. doi: 10.1371/journal.pone.0216255. eCollection 2019.

29.

Cancer diagnosis and risk of suicide after accounting for prediagnosis psychiatric care: A matched-cohort study of patients with incident solid-organ malignancies.

Klaassen Z, Wallis CJD, Chandrasekar T, Goldberg H, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS.

Cancer. 2019 Aug 15;125(16):2886-2895. doi: 10.1002/cncr.32146. Epub 2019 Apr 25.

PMID:
31021430
30.

Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer.

Williams SB, Hudgins HK, Ray-Zack MD, Chamie K, Smaldone MC, Boorjian SA, Daneshmand S, Black PC, Kamat AM, Goebell PJ, Seiler R, Schmitz-Drager B, Nawroth R, Baillargeon J, Klaassen Z, Kulkarni GS, Kim SP, Lee EK, Holzbeierlein JM, Hollenbeck BK, Gore JL.

Eur Urol Oncol. 2019 Mar;2(2):119-125. doi: 10.1016/j.euo.2018.07.006. Epub 2018 Aug 14.

PMID:
31017086
31.

Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.

Goldberg H, Ramiz AH, Glicksman R, Salgado NS, Chandrasekar T, Klaassen Z, Wallis CJD, Hosni A, Moraes FY, Ghai S, Kulkarni GS, Hamilton RJ, Perlis N, Toi A, Chung P, Evans A, van der Kwast T, Finelli A, Fleshner N, Berlin A.

Eur Urol Oncol. 2019 Feb;2(1):88-96. doi: 10.1016/j.euo.2018.05.003. Epub 2018 May 27.

PMID:
30929849
32.

Risk of Bone Fractures Following Urinary Intestinal Diversion: A Population Based Study.

Richard PO, Bashir S, Riverin BD, Alibhai SMH, Kim SJ, Ahmad A, Fleshner NE, Gupta A, Mohammed A, Zlotta AR, Kulkarni GS.

J Urol. 2019 Aug;202(2):319-325. doi: 10.1097/JU.0000000000000213. Epub 2019 Jul 8.

PMID:
30865566
33.

The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies.

Klaassen Z, Wallis CJD, Goldberg H, Chandrasekar T, Sayyid RK, Williams SB, Moses KA, Terris MK, Nam RK, Urbach D, Austin PC, Kurdyak P, Kulkarni GS.

Br J Cancer. 2019 Apr;120(8):840-847. doi: 10.1038/s41416-019-0390-0. Epub 2019 Mar 6.

PMID:
30837680
34.

Laparoscopic repair of a combined transmesocolic, transomental hernia.

Kulkarni GV, Premchandani D, Chitnis A, Katara A, Bhandarkar DS.

J Minim Access Surg. 2020 Jan-Mar;16(1):83-86. doi: 10.4103/jmas.JMAS_244_18.

35.

Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.

Chung J, Kulkarni GS, Morash R, Matthew A, Papadakos J, Breau RH, Guttman D, Bender J, Jones JM.

Support Care Cancer. 2019 Oct;27(10):3877-3885. doi: 10.1007/s00520-019-4649-z. Epub 2019 Feb 14.

36.

Canadian Urological Association guideline: Muscle-invasive bladder cancer.

Kulkarni GS, Black PC, Sridhar SS, Kapoor A, Zlotta AR, Shayegan B, Rendon RA, Chung P, van der Kwast T, Alimohamed N, Fradet Y, Kassouf W.

Can Urol Assoc J. 2019 Jan 31:230-238. doi: 10.5489/cuaj.5902. [Epub ahead of print] No abstract available.

37.

Are there differences between de novo and secondary upper tract urothelial carcinoma tumours?

Goldberg H, Cheung DC, Chandrasekar T, Klaassen Z, Wallis CJD, Kulkarni GS, Sayyid R, Evans A, Masoomian M, Bapat B, van der Kwast T, Hamilton RJ, Zlotta A, Fleshner N.

Can Urol Assoc J. 2019 Jan 21:E292-E299. doi: 10.5489/cuaj.5595. [Epub ahead of print]

38.

Clinical, electrophysiological and laboratory parameters, and outcome in patients with biopsy proven systemic and nonsystemic vasculitic neuropathy.

Ramineni KK, Chandra SR, Mahadevan A, Kulkarni GB, Ramanujam CN.

Neurol India. 2019 Jan-Feb;67(Supplement):S62-S70. doi: 10.4103/0028-3886.250709.

39.

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer.

Ajib K, Kulkarni GS.

Transl Androl Urol. 2018 Dec;7(Suppl 6):S723-S726. doi: 10.21037/tau.2018.10.01. No abstract available.

40.

Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.

Jiang DM, Jiang H, Chung PWM, Zlotta AR, Fleshner NE, Bristow RG, Berlin A, Kulkarni GS, Alimohamed NS, Lo G, Sridhar SS.

Clin Genitourin Cancer. 2019 Feb;17(1):38-45. doi: 10.1016/j.clgc.2018.09.021. Epub 2018 Oct 4.

PMID:
30686350
41.

Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.

Nayan M, Punjani N, Juurlink DN, Finelli A, Austin PC, Kulkarni GS, Uleryk E, Hamilton RJ.

Am J Clin Oncol. 2019 Mar;42(3):275-284. doi: 10.1097/COC.0000000000000512.

PMID:
30663998
42.

Introducing an automated high content confocal imaging approach for Organs-on-Chips.

Peel S, Corrigan AM, Ehrhardt B, Jang KJ, Caetano-Pinto P, Boeckeler M, Rubins JE, Kodella K, Petropolis DB, Ronxhi J, Kulkarni G, Foster AJ, Williams D, Hamilton GA, Ewart L.

Lab Chip. 2019 Jan 29;19(3):410-421. doi: 10.1039/c8lc00829a.

PMID:
30663729
43.

Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.

Samvedna S, Jindal S, Mishra G, Madan JR, Gupta G, Awasthi R, Pinto TJA, Dua K, Kulkarni GT.

Polim Med. 2018 Jan-Jun;48(1):31-40. doi: 10.17219/pim/99951.

44.

Atmo-ecometabolomics: a novel atmospheric particle chemical characterization methodology for ecological research.

Rivas-Ubach A, Liu Y, Steiner AL, Sardans J, Tfaily MM, Kulkarni G, Kim YM, Bourrianne E, Paša-Tolić L, Peñuelas J, Guenther A.

Environ Monit Assess. 2019 Jan 16;191(2):78. doi: 10.1007/s10661-019-7205-x.

PMID:
30649631
45.

Alcohol Dependence, Hypoglycemia, and Transient Movement Disorders.

Shukla L, Reddy S, Kulkarni G, Chand PK, Murthy P.

Prim Care Companion CNS Disord. 2019 Jan 3;21(1). pii: 18l02308. doi: 10.4088/PCC.18l02308. No abstract available.

46.

The Prostate Cancer Rehabilitation Clinic: a biopsychosocial clinic for sexual dysfunction after radical prostatectomy.

Matthew A, Lutzky-Cohen N, Jamnicky L, Currie K, Gentile A, Mina DS, Fleshner N, Finelli A, Hamilton R, Kulkarni G, Jewett M, Zlotta A, Trachtenberg J, Yang Z, Elterman D.

Curr Oncol. 2018 Dec;25(6):393-402. doi: 10.3747/co.25.4111. Epub 2018 Dec 1.

47.

Concerns about modelling of the EDGES data.

Hills R, Kulkarni G, Meerburg PD, Puchwein E.

Nature. 2018 Dec;564(7736):E32-E34. doi: 10.1038/s41586-018-0796-5. Epub 2018 Dec 19. No abstract available.

PMID:
30568200
48.

The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.

Chandrasekar T, Goldberg H, Klaassen Z, Wallis CJD, Woon DTS, Herrera-Caceres JO, Kulkarni GS, Fleshner NE.

Cancer. 2019 Apr 1;125(7):1050-1059. doi: 10.1002/cncr.31916. Epub 2018 Dec 18.

PMID:
30561782
49.

Montelukast Sodium Formulation Containing Green Tea Extract to Reduce the Oxidative Stress in Guinea Pig Model of Chronic Allergic Asthma.

Singh N, Kulkarni GT, Kumar Y.

Recent Pat Drug Deliv Formul. 2018;12(4):267-276. doi: 10.2174/1872211313666181211123903.

PMID:
30539707
50.

Cosmetically Adaptable Transparent Strain Sensor for Sensitively Delineating Patterns in Small Movements of Vital Human Organs.

Gupta N, Rao KDM, Srivastava K, Gupta R, Kumar A, Marconnet A, Fisher TS, Kulkarni GU.

ACS Appl Mater Interfaces. 2018 Dec 19;10(50):44126-44133. doi: 10.1021/acsami.8b16282. Epub 2018 Dec 5.

PMID:
30468065

Supplemental Content

Loading ...
Support Center